NCAM1 and COVID-19: Compared with mild COVID-19 patients, severe COVID-19 patients had lower peripheral CD3+ T lymphocyte count and CD3+ CD4+ T lymphocyte count, especially CD3+ CD8+ T lymphocytes and CD16+ CD56+ NK cells.